Multicentric warfarin-induced skin necrosis complicating heparin-induced thrombocytopenia

American Journal of Hematology

Volumn 62, Issue 1, 1999, Pages 44-48

  Warkentin, Theodore E ^a,d   Sikov, William M ^b   Lillicrap, David P ^c  

^a MCMASTER UNIVERSITY   (Canada)

^b BROWN UNIVERSITY   (United States)

^c QUEEN S UNIVERSITY   (Canada)

^d HAMILTON HEALTH SCIENCES   (Canada)

Author keywords

Heparin; Protein C; Protein S; Skin necrosis; Thrombocytopenia; Warfarin

Indexed keywords

HEPARIN; WARFARIN;

ABOVE KNEE AMPUTATION; ADULT; AGED; ARTICLE; BREAST; CASE REPORT; DEEP VEIN THROMBOSIS; DRUG INDUCED DISEASE; FACE; FEMALE; GANGRENE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG EMBOLISM; MASTECTOMY; PRIORITY JOURNAL; RISK FACTOR; SKIN NECROSIS; THIGH; THROMBOCYTOPENIA; THROMBOEMBOLISM;

ADRENAL GLAND DISEASES; AGED; AMPUTATION; ANTICOAGULANTS; ANTIGENS, HUMAN PLATELET; AUTOANTIBODIES; AUTOIMMUNE DISEASES; DATABASES, FACTUAL; DISSEMINATED INTRAVASCULAR COAGULATION; ECCHYMOSIS; FATAL OUTCOME; FEMALE; GANGRENE; HEMORRHAGE; HEPARIN; HUMANS; MASTECTOMY; MIDDLE AGED; MULTIPLE ORGAN FAILURE; NECROSIS; POSTOPERATIVE COMPLICATIONS; PULMONARY EMBOLISM; SKIN; SKIN DISEASES; THIGH; THROMBIN; THROMBOCYTOPENIA; THROMBOPHILIA; THROMBOPHLEBITIS; VENA CAVA FILTERS; WARFARIN;

EID: 0032873201     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8652(199909)62:1<44::AID-AJH7>3.0.CO;2-F     Document Type: Article

References (36)

1. Cole MS, Minifee PK, Wolma FJ: Coumarin necrosis-a review of the literature. Surgery 1988;103:271-277.
2. Elby CS: Warfarin-induced skin necrosis. Hematol/Oncol Clin N Am 1993;7:1291-1300.
3. Sallah S, Thomas DP, Roberts HR: Warfarin and heparin-induced skin necrosis and the purple toe syndrome: infrequent complications of anticoagulant treatment. Thromb Haemost 1997;78:785-790.
4. Lewandowski K, Zawilska K: Protein C concentrate in the treatment of warfarin-induced skin necrosis in the protein C deficiency (letter). Thromb Haemost 1994;71:395-399.
5. Schramm W, Spannagl M, Bauer KA, Rosenberg RD, Birkner B, Linnau Y, Schwarz HP: Treatment of coumarin-induced skin necrosis with a monoclonal antibody purified protein C concentrate. Arch Dermatol 1993;129:753-756.
6. Broekmans AW, Bertina RM, Loeliger EA, Hofmann V, Klingemann HG: Protein C and the development of skin necrosis during anticoagulant therapy (letter). Thromb Haemost 1983;49:251.
7. Anderson DR, Brill-Edwards P, Walker I: Warfarin-induced skin necrosis in 2 patients with protein S deficiency: Successful reinstatement of warfarin therapy. Haemostasis 1992;22:124-128.
8. Grimaudo V, Gueissaz F, Hauert J, Sarraj A, Kruithof EKO, Bachmann F: Necrosis of skin induced by coumarin in a patient deficient in protein S. Br Med J 1989;298:233-234.
9. Craig A, Taberner DA, Fisher AH, Foster DN, Mitra J: Type I protein S deficiency and skin necrosis. Postgrad Med J 1990;66:389-391.
10. Keihl R, Hellstern P, Wenzel E: Hereditary antithrombin III deficiency and atypical localization of a coumadin necrosis. Thromb Res 1987; 45:191-193.
11. Colman RW, Rao AK, Rubin RN: Warfarin skin necrosis in a 33-year-old woman. Am J Hematol 1993;43:300-303.
12. Makris M, Bardhan G, Preston FE: Warfarin induced skin necrosis associated with activated protein C resistance (letter). Thromb Haemost 1995;75:523-524.
13. Stirling Y: Warfarin-induced changes in procoagulant and anticoagulant proteins. Blood Coag Fibrinol 1995;6:361-373.
14. Sheridan D, Carter C, Kelton JG: A diagnostic test for heparin-induced thrombocytopenia. Blood 1986;67:27-30,
15. Warkentin TE, Hayward CPM, Smith CA, Kelly PM, Kelton JG: Determinants of donor platelet variability when testing for heparin-induced thrombocytopenia. J Lab Clin Med 1992;120:371-379.
16. Warkentin TE, Levine MN, Hirsh J, Horsewood P, Roberts RS, Gent M, Kelton JG: Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med 1995;332:1330-1335.
17. Warkentin TE, Kelton JG: A 14-year study of heparin-induced thrombocytopenia. Am J Med 1996;101:502-507.
18. Warkentin TE: Heparin-induced skin lesions. Br J Haematol 1996;92: 494-497.
19. Warkentin TE, Elavathil LJ, Hayward CPM, Johnston MA, Russett JI, Kelton JG: The pathogenesis of venous limb gangrene associated with heparin-induced thrombocytopenia. Ann Intern Med 1997;127:804-812.
20. Warkentin TE: Heparin-induced thrombocytopenia: IgG-mediated platelet activation, platelet microparticle generation, and altered procoagulant/anticoagulant balance in the pathogenesis of thrombosis and venous limb gangrene complicating heparin-induced thrombocytopenia. Transf Med Rev 1996;10:249-258.
21. Isenberg JS, Tu Q, Rainey W: Mammary gangrene associated with warfarin ingestion. Ann Plast Surg 1996;37:553-555.
22. Celoria GM, Steingart RH, Banson B, Friedmann P, Rhee SW, Berman JA: Coumarin skin necrosis in a patient with heparin-induced thrombocytopenia-a case report. Angiology 1988;39:915-920.
23. Cohen DJ, Briggs R, Head HD, Acher CW: Phlegmasia cerulea dolens and its association with hypercoagulable states: Case reports. Angiology 1989;40:498-500.
24. Drakos P, Uziely B, Nagler A, Gillis S, Eldor A: Successful administration of low molecular weight heparin in a patient with heparin-induced thrombocytopenia and coumarin-induced skin necrosis. Haemostasis 1993;23:259-262.
25. Hermes B, Haas N, Henz BM: Immunopathological events of adverse cutaneous reactions to coumarin and heparin. Acta Derm Venereol 1997;77:35-38.
26. Shahak A, Pósán E, Szücs G, Rigó J, Boda Z: Coumarin-induced skin necrosis following heparin-induced thrombocytopenia and thrombosis. A case report. Angiology 1996;47:725-727.
27. Everett RN, Jones FL Jr: Warfarin-induced skin necrosis. A cutaneous sign of malignancy? Postgrad Med 1986;79:97-103.
28. Conlan MG, Bridges A, Williams E, Marlar R: Familial type II protein C deficiency associated with warfarin-induced skin necrosis and bilateral adrenal hemorrhage. Am J Hematol 1988;29:226-229.
29. Muntean W, Finding K, Gamillscheg A, Zenz W: Multiple thromboses and coumarin-induced skin necrosis in a young child with antiphospholipid antibodies. Thromb Haemorrh Disorders 1992;5:43-45.
30. Warkentin TE: Limitations of conventional treatment options for heparin-induced thrombocytopenia. Semin Hematol 1998;35(Suppl. 5): 17-25.
31. Cines DB, Tomaski A, Tannenbaum S: Immune endothelial-cell injury in heparin-associated thrombocytopenia. N Engl J Med 1987;316:581-589.
32. Visentin GP, Ford SE, Scott JP, Aster RH: Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells. J Clin Invest 1994;93:81-88.
33. Warkentin TE, Hayward CPM, Boshkov LK, Santos AV, Sheppard JI, Bode AP, Kelton JG: Sera from patients with heparin-induced thrombocytopenia generate platelet-derived microparticles with procoagulant activity: an explanation for the thrombotic complications of heparin-induced thrombocytopenia. Blood 1994;84:3691-3699.
34. Tans G, Rosing J, Thomassen MC, Heeb MJ, Zwaal RF, Griffin JH: Comparison of anticoagulant and procoagulant activities of stimulated platelets and platelet-derived microparticles. Blood 1991;77:2641-2648.
35. Markwardt F: Hirudin: the promising antithrombotic. Cardiovasc Drug Rev 1992;10:211-232.
36. Warkentin TE, Chong BH, Greinacher A: Heparin-induced thrombocytopenia: towards consensus. Thromb Haemost 1998;79:1-7.